Vnitr Lek 2009, 55(2):89-90

Metabolický syndrom, tělesná hmotnost a žilní trombóza - editorial

P. Sucharda
III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Received: January 3, 2009; Published: February 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sucharda P. Metabolický syndrom, tělesná hmotnost a žilní trombóza - editorial. Vnitr Lek. 2009;55(2):89-90.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-1209. Go to original source... Go to PubMed...
    2. Sucharda P. Abdominální obezita. Čas Lék Čes 2009; 148 (v tisku).
    3. Sucharda P. Abdominální obezita - epidemie 21. století. Kardiol Rev 2008; 10: 165-167.
    4. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International diabetes federation. Diabet Med 2006; 23: 469-480. Go to original source... Go to PubMed...
    5. Rector RS, Thyfault JP, Wei Y et al. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol 2008; 14: 185-192. Go to original source... Go to PubMed...
    6. Ketel IJ, Stehouwer CD, Serné EH et al. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 2008; 93: 3365-3372. Go to original source... Go to PubMed...
    7. Eichinger S, Hron G, Bialonczyk C et al. Overweight, obesity, and the risk of recurrent venous thrombosis. Arch intern Med 2008; 168: 1678-1683. Go to original source... Go to PubMed...
    8. Ageno W, Prandoni P, Romualdi E et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006; 4: 1914-1918. Go to original source... Go to PubMed...
    9. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497. Go to PubMed...
    10. Ay C, Tengler T, Vormittag R et al. Venous thromboembolism - a manifestation of the metabolic syndrome. Haematologica 2007; 92: 374-380. Go to original source... Go to PubMed...
    11. Ray JG, Lonn E, Yi Q et al. Venous thromboembolism in association with features of the metabolic syndrome. Q J Med 2007; 100: 679-684. Go to original source... Go to PubMed...
    12. Borch KH, Braekkan SK, Mathiesen EB et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome - the Tromsø study. J Thromb Haemost 2008; 22 [Epub ahead of print].
    13. Sundell B, Nilsson TK, Randy M et al. Fibrinolytic variables are related to age, sex, blood pressure, and body build measurements: a cross-sectional study in Norsjö, Sweden. J Clin Epidemiol 1989; 42: 719-723. Go to original source... Go to PubMed...
    14. Landin K, Stigendal L, Eriksson E et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044-1048. Go to original source... Go to PubMed...
    15. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-161. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.